Royalty Report: Assay, Scientific & Technical Instruments, Technical Know How – Collection: 294486

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 4

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 4

Primary Industries

  • Assay
  • Scientific & Technical Instruments
  • Technical Know How
  • Drug Discovery
  • Drugs
  • Proteins

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 294486

License Grant
With respect to Components of the System developed by Licensor to be used in a System in the Field, Licensor shall grant a license, under Licensors Intellectual Property and Intellectual Property Rights to make, have made, use, have used, sell and have sold such Components developed in the Development Phase solely for incorporation into a System developed or proposed to be developed under the affected Program and commercialization of the System.

Licensee shall have the exclusive right to make or have made, use, have used, sell and have sold the affected System and Components designed specifically for the System for use with Oasis LabCard chips in the Field.

For the duration of the Development Phase for each Program, each Party is granted a license under the Intellectual Property Rights of the other Party to use Systems and Components to the extent reasonably necessary to satisfy its obligations under this Agreement.

For the duration of the Commercialization Phase for each Program, each Party is granted a license under the Intellectual Property Rights of the other Party to use Systems and the individual Components incorporated into such Systems to the extent reasonably necessary to exercise its rights and satisfy its obligations under this Agreement.

License Property
Licensor has certain skills, know-how and intellectual property for products related to, reagents for homogeneous biochemical and cell-based assays, automated fluid handling devices (including piezo electric dispensers), plate tracking and stacking devices, detectors for measuring biological reactions, software and the capability for the marketing, sales and support of such products.

LOCI shall mean the technology owned or licensed by Licensor relating to luminescent oxygen channeling assays and described in U.S. Patent application Serial No. 704,569, filed May 22, 1991 and U.S. Patent application Serial No. 718,490 filed June 20, 1991.

Oasis LabCard chips shall mean any microfluidic analytical device that has one or more small reaction vessels~connected to and over a capillary channel, which is in turn connected to a source of replenishing liquid, and that does not require the use of electrical fields to facilitate the movement of fluids through the capillary channel.

Field of Use
Field shall mean any application of an Oasis LabCard chip in performing Homogeneous Assays wherein, except for immobilization of reagents in the Oasis LabCard chip prior to sale for use with an assay not requiring a washing step, the surfaces of the Oasis LabCard chip are not modified for binding events.

IPSCIO Record ID: 294004

License Grant
With respect to Oasis LabCard chips and/capillary pin dispenser module developed by Licensor, Licensor  grants to a license under Licensors Intellectual Property and Intellectual Property Rights to make, have made, use, have used, sell and have sold Oasis LabCard chips developed in the Development Phase solely for incorporation into a System developed or proposed to be developed under the affected Program and commercialization of the System.

For the duration of the Commercialization Phase for each Program, Licensee is granted a license under the Intellectual Property Rights of Licensor to the extent reasonably necessary to commercialize the Systems as contemplated above and to manufacture capillary pin dispensers.

Licensee shall have the exclusive right to make or have made, use, have used, sell and have sold the affected System and Components designed specifically for the System for use with Oasis LabCard chips in the Field.

For the duration of the Development Phase for each Program, each Party is granted a license under the Intellectual Property Rights of the other Party to use Systems and Components to the extent reasonably necessary to satisfy its obligations under this Agreement.

For the duration of the Commercialization Phase for each Program, each Party is granted a license under the Intellectual Property Rights of the other Party to use Systems and the individual Components incorporated into such Systems to the extent reasonably necessary to exercise its rights and satisfy its obligations under this Agreement.

License Property
Licensor has certain skills, know-how and intellectual property for products related to microfluidic analytic devices, dispensers and reagents for use in such chips and the capability for the manufacture of such products.

LOCI shall mean the technology owned or licensed by Licensee relating to luminescent oxygen channeling assays and described in U.S. Patent application Serial No. 704,569, filed May 22, 1991 and U.S. Patent application Serial No. 718,490 filed June 20, 1991.

Oasis LabCard chips shall mean any microfluidic analytical device that has one or more small reaction vessels~connected to and over a capillary channel, which is in turn connected to a source of replenishing liquid, and that does not require the use of electrical fields to facilitate the movement of fluids through the capillary channel.

Field of Use
Field shall mean any application of an Oasis LabCard chip in performing Homogeneous Assays wherein, except for immobilization of reagents in the Oasis LabCard chip prior to sale for use with an assay not requiring a washing step, the surfaces of the Oasis LabCard chip are not modified for binding events.

IPSCIO Record ID: 282900

License Grant
For a sublicense of rights granted by a University for Reagents, the UC Reagents Sublicense, effective upon execution of the UC License, Licensor grants to Licensee, without any requirement for execution of a further agreement, a worldwide, exclusive sublicense under the UC License to make, have made and sell the Licensors UC Reagents to non-profit organizations, e.g:, academic institutes, government laboratories, research hospitals, medical schools, solely for use for their internal, non-commercial research.

For a period of 3 years from and after the date of the first delivery to Licensor of production quality NANO-PLATES for production run purposes, Licensee shall have the exclusive right to use, lease, and sell NANO-PLATES outside the HTS and Automated Chemistry markets.

License Property
Licensor possesses bioreagents, chemical probes, instrumentation and imaging technology for miniaturization and high-throughput analysis of cell-based and biochemical assays.

Assay shall mean any biological assay for the fluorescent measurement and analysis of biological reactions using Licensor technology.

Automated Chemistry shall mean chemistry applications utilizing automation for synthesizing compounds or drug candidates to be used for drug or agrochemical discovery.

HTS shall mean the High-Throughput Screening of drug or agrochemical candidates.

Licensor Reagents shall mean reagents, biological materials and chemical Probes owned or controlled by Licensor that are used or are useful in life sciences research and drug discovery, including but not limited to, Licensors UC Reagents.

Licensor UC Reagents shall mean all bioreagents, biological materials and chemical probes within a claim of the patent rights licensed to Licensor under the UC License.

The Licensor is developing novel screening plates (NanoPlates) and innovative microfluidics to enable miniaturized assays in volumes approximately 100 times smaller than conventional screens. Smaller volumes reduce the amount of expensive or scarce reagents that may be required in a screen.

Field of Use
The sublicense is for use by Licensee for internal, non-commercial research.

Licensee possesses instrumentation, reagents and assay technology for the high-throughput sample preparation and analysis of biological assays.

IPSCIO Record ID: 286051

License Grant
The Licensor of England grants the exclusive rights to make have made use and sell Products and to practice the methods described in the said Patent Rights to conduct clinical assays.

Licensor shall promptly after the date hereof disclose to Licensee all Proprietary Information owned or controlled by Licensor which is reasonably necessary to enable Licensee to make have made use and sell Products and to apply Chemiluminescence Technology to clinical diagnostic assay products and procedures and Licensor grants to Licensee the right and license to use such Proprietary Information to make or have made Products in the Countries identified and to use and sell Products and to perform clinical assays throughout the world.

Licensor agrees to grant to Licensee an exclusive license under all patent rights inventions know-how and proprietary information that it may hereafter come to own or control or shall have the right to sublicense during the Term of this Agreement and which cover or relate to improvements to Licensors licensed Patent Rights Products or to the assays agreed by Licensor and Licensee to enable Licensee to use such Patent rights inventions know-how and Proprietary Information to improve such Products and assays.

If Licensor develops new diagnostic immunoassay and binding protein tests based upon the Chemiluminescence Technology during the Term other than the assays identified and which are not improvements to such assays Licensor shall promptly and exclusively advise Licensee in writing of the availability of such assays and shall make available to Licensee all information in the possession of Licensor regarding such assays and shall give Licensee 120 days to make a proposal to Licensor whereby Licensee shall obtain licenses to make have made use and sell such assays Licensor shall accept or reject Licensees proposal.

License Property
The Licensor property was granted to Licensor by a University, the rights to the techniques for the measurement of the presence of antibodies, binding proteins and other analytes based upon the phenomenon of chemiluminescence.  The University inventions are specifically pertaining to Chemiluminescence Technology.

The technology is a proprietary technique for measurements based upon the phenomenon of chemiluminescence for which the University has applied for patent protection.

The Chemiluminescence technology is the body of knowledge inclusive of the Universitys Patent Rights and Proprietary Information relating to the quantification of substances utilizing light energy emissions resulting from reactions involving such substances that is useful in immunoassay and binding protein assay systems.

The Products are Clinical diagnostic kits and components of diagnostic kits the manufacture sale or use of which would constitute an infringement of the Universitys Patent rights but for the licenses granted hereby or which incorporate to a substantial degree technical Proprietary Information.

Field of Use
The field of use is measurement technology to clinical diagnostic immunoassay and binding protein assay systems developed.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.